Forbes

In this week’s edition of InnovationRx, we look at the potential impact of Trump’s executive order on vaccines, the healthcare dynamos on Forbes 50 Over 50, a Swiss startup focused on a rare bleeding disorder, and more.

New antibodies recognize mutant KRAS fragments displayed on tumor cells, unlocking a way to target pancreatic, colorectal, and lung cancers.

Trump signed an executive order to reshape the childhood vaccine schedule. He made multiple false claims, including repeating the debunked vaccines and autism link.

The first genomes from Congo's Bundibugyo Ebola outbreak point to a recent animal spillover, but are too few to date when the jump happened.

The digitization of medical records, mandated by the HITECH Act of 2009, achieved near-universal adoption but brought substantial unintended consequences.

Pediatric health is critically underfunded, despite 1/3 of the global population being kids. But the ROI of investing in kids yields profound health and economic returns.

A psychiatrist explains why postpartum psychosis is so often missed by doctors — and what needs to change in how it's diagnosed and treated.

A reproductive psychiatrist explains differences in maternal mental health diagnoses and why the distinctions matter.

President Trump's new executive order on vaccines raises a number of public health concerns. A physician breaks those down.

Daily cannabis use is surging as potency quadruples. An ER doctor explains the real risks: addiction, withdrawal, psychosis, heart disease, and lung cancer.

Two undisclosed deaths in Chinese gene-editing trials renew concerns about trial oversight, safety reporting, and transparency as gene therapy advances worldwide.

Hospitals often earn large spreads on high-volume branded drugs bought via 340B. Reforms may make hospitals more price-sensitive, raisin uptake of lower-cost biosimilars.

GLP-1s are known for weight loss. A physician reviews 7 evidence-backed benefits, from kidney and liver disease to sleep apnea, addiction, clots and cancer progression.

The FDA is weighing whether six experimental peptides should become available through compounding pharmacies. A better answer is neither yes nor no.

A doctor answers common questions on the Salmonella jalapeño outbreak and explains why food borne illnesses continue to rise in America.